Prof. Dr. Ludwig Plasswilm
chief physician
Department of Radiation Oncology · Dept. IV
Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
Hundsberger T, Brügge D, Putora P, Weder P, Weber J, Plasswilm L. Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas. J Neurooncol 2013; 112:133-9.
Jan 12, 2013Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas
Jan 12, 2013J Neurooncol 2013; 112:133-9
Hundsberger Thomas, Brügge Detlef, Putora Paul Martin, Weder Patrik, Weber Johannes, Plasswilm Ludwig
Re-implantation after insufficient primary 125-I permanent prostate brachytherapy
Putora P, Plasswilm L, Seelentag W, Schiefer J, Markart P, Schmid H, Engeler D. Re-implantation after insufficient primary 125-I permanent prostate brachytherapy. Radiat Oncol 2013; 8:194.
Jan 1, 2013Re-implantation after insufficient primary 125-I permanent prostate brachytherapy
Jan 1, 2013Radiat Oncol 2013; 8:194
Putora Paul Martin, Plasswilm Ludwig, Seelentag Wolf, Schiefer Johann, Markart Patrick, Schmid Hans-Peter, Engeler Daniel
Seed Migration nach LDR-Brachytherapie der Prostata mit J-125 Permanentimplantation
Abt D, Markart P, Schwab C, Engeler D, Schiefer J, Plasswilm L, Schmid H (2013). Seed Migration nach LDR-Brachytherapie der Prostata mit J-125 Permanentimplantation.
Jan 1, 2013Seed Migration nach LDR-Brachytherapie der Prostata mit J-125 Permanentimplantation
Jan 1, 2013-
Abt Dominik, Markart Patrick, Schwab Christoph, Engeler Daniel, Schiefer Johann, Plasswilm Ludwig, Schmid Hans-Peter
Bounce-Phänomen als prognostisch günstiger Faktor nach LDR-Brachytherapie - prospektive Auswertung des schweizerischen Registers
Schwab C, Schmid H, Plasswilm L, Engeler D. Bounce-Phänomen als prognostisch günstiger Faktor nach LDR-Brachytherapie - prospektive Auswertung des schweizerischen Registers. Urologe 2013; 52 (suppl 1):101.
Jan 1, 2013Bounce-Phänomen als prognostisch günstiger Faktor nach LDR-Brachytherapie - prospektive Auswertung des schweizerischen Registers
Jan 1, 2013Urologe 2013; 52 (suppl 1):101
Schwab Christoph, Schmid Hans-Peter, Plasswilm Ludwig, Engeler Daniel
Compensability index for compensation radiotherapy after treatment interruptions
Putora P, Schmücking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiation Oncology 2012; 2012:208.
Dec 8, 2012Compensability index for compensation radiotherapy after treatment interruptions
Dec 8, 2012Radiation Oncology 2012; 2012:208
Putora Paul Martin, Schmücking Michael, Aebersold D, Plasswilm Ludwig
Compensability index for compensation radiotherapy after treatment interruptions
Putora P, Schmuecking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiat Oncol 2012; 7:208.
Dec 8, 2012Compensability index for compensation radiotherapy after treatment interruptions
Dec 8, 2012Radiat Oncol 2012; 7:208
Putora Paul Martin, Schmuecking Michael, Aebersold Daniel, Plasswilm Ludwig
Surface dose optimization of the Varian Ir-192 HDR surface applicator set
Buchauer K, Schiefer J, Plasswilm L (2012). Surface dose optimization of the Varian Ir-192 HDR surface applicator set.
Nov 15, 2012Surface dose optimization of the Varian Ir-192 HDR surface applicator set
Nov 15, 201247th SSRMP Annual Scientific Meeting SSRMP 2012
Buchauer Konrad, Schiefer Johann, Plasswilm Ludwig
Post Irradiation Sign of Progress in Anaplastic Ependymoma - A Case Report
Horstkemper R, Brügge D, Müller J, Mock B, Plasswilm L (2012). Post Irradiation Sign of Progress in Anaplastic Ependymoma - A Case Report.
Apr 20, 2012Post Irradiation Sign of Progress in Anaplastic Ependymoma - A Case Report
Apr 20, 2012SASRO 2012
Horstkemper Ruth, Brügge Detlef, Müller Joachim, Mock B, Plasswilm Ludwig
Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma
Horstkemper R, Putora P, Toepfer M, Plasswilm L (2012). Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma.
Apr 19, 2012Good Reponse of Palliative Radiotherapy for Very Advanced Metastastic Melanoma
Apr 19, 2012-
Horstkemper Ruth, Putora Paul Martin, Toepfer Michael, Plasswilm Ludwig
Spinal Cord Myxopapillary Ependymoma in a 15 Years Old Boy
Naef G, Brügge D, Plasswilm L (2012). Spinal Cord Myxopapillary Ependymoma in a 15 Years Old Boy.
Apr 19, 2012Spinal Cord Myxopapillary Ependymoma in a 15 Years Old Boy
Apr 19, 2012SASRO 2012
Naef Gabriela, Brügge Detlef, Plasswilm Ludwig
Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes)
Putora P, Horstkemper R, Papachristofilou A, Plasswilm L (2012). Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes).
Apr 19, 2012Manipulation and Quality Assurance of Guidelines; an Online Implementation of Diagnostic Nodes (Dodes)
Apr 19, 2012SASRO 2012
Putora Paul Martin, Horstkemper Ruth, Papachristofilou A, Plasswilm Ludwig
Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications
Putora P, Horstkemper R, Müller J, Plasswilm L (2012). Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications.
Apr 19, 2012Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications
Apr 19, 2012SASRO 2012
Putora Paul Martin, Horstkemper Ruth, Müller Joachim, Plasswilm Ludwig
Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
Schallegger K, Brügge D, Hitz F, Hundsberger T, Cathomas R, Plasswilm L (2012). Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis.
Apr 19, 2012Case Report of a patient with LGL-Leukemia who Developed a Leptomeningeal Lymphomatosis
Apr 19, 2012SASRO 2012
Schallegger K, Brügge Detlef, Hitz Felicitas, Hundsberger Thomas, Cathomas R, Plasswilm Ludwig
Dosimetric Validation of Eclipse VMAT Plans for Elekta Units Using a Modified Octavius Verification Technique
Naef G, Schiefer J, Peters S, Orvati C, Plasswilm L (2012). Dosimetric Validation of Eclipse VMAT Plans for Elekta Units Using a Modified Octavius Verification Technique.
Apr 19, 2012Dosimetric Validation of Eclipse VMAT Plans for Elekta Units Using a Modified Octavius Verification Technique
Apr 19, 2012SASRO 2012
Naef Gabriela, Schiefer Johann, Peters Samuel, Orvati C, Plasswilm Ludwig
Customized Lung Phantom for Internal Target Volume Evaluation
Putora P, Fornaro J, Devecka M, Duma M, Plasswilm L (2012). Customized Lung Phantom for Internal Target Volume Evaluation.
Apr 19, 2012Customized Lung Phantom for Internal Target Volume Evaluation
Apr 19, 2012SASRO 2012
Putora Paul Martin, Fornaro Jürgen, Devecka M, Duma MN, Plasswilm Ludwig
Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome
Klass N, Aebersold D, Krause T, Plasswilm L, Blumstein N, Born E, Cihoric N, Schmidhalter D, Früh M, Malthaner M, Toepfer M, Klaeser B, Schmuecking M (2012). Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome.
Apr 19, 2012Non-Gated F-18 FDG PET/CT For Target Volume Delineation in Stereotactic Body Radiation Therapy (SBRT) in Patients with Malignant Lung Lesions and Clinical Outcome
Apr 19, 2012SASRO 2012
Klass ND, Aebersold D, Krause T, Plasswilm Ludwig, Blumstein N, Born E, Cihoric N, Schmidhalter D, Früh Martin, Malthaner M, Toepfer Michael, Klaeser B, Schmuecking M
Palliative Radiotherapie beim NSCLC
Putora P, Horstkemper R, Plasswilm L. Palliative Radiotherapie beim NSCLC - Indikationen und Verfahren. Schweizerische Zeitschrift für Onkologie 2012; 1:12-16.
Feb 21, 2012Palliative Radiotherapie beim NSCLC
Feb 21, 2012Schweizerische Zeitschrift für Onkologie 2012; 1:12-16
Putora Paul Martin, Horstkemper Ruth, Plasswilm Ludwig
Castration-resistant prostate cancer : Surgical and radio-oncological therapeutic options
Preusser S, Putora P, Plasswilm L, Schmid H. Castration-resistant prostate cancer : Surgical and radio-oncological therapeutic options. Der Urologe 2012; 51:27-31.
Jan 22, 2012Castration-resistant prostate cancer : Surgical and radio-oncological therapeutic options
Jan 22, 2012Der Urologe 2012; 51:27-31
Preusser Stefan, Putora Paul Martin, Plasswilm Ludwig, Schmid Hans-Peter
Reimplantation nach insuffizienter primärer I-125 LDR-Brachytherapie beim Prostatakarzinom
Engeler D, Putora P, Plasswilm L, Seelentag W, Schiefer J, Schmid H (2011). Reimplantation nach insuffizienter primärer I-125 LDR-Brachytherapie beim Prostatakarzinom.
Sep 14, 2011Reimplantation nach insuffizienter primärer I-125 LDR-Brachytherapie beim Prostatakarzinom
Sep 14, 201163. Kongress der Deutschen Gesellschaft für Urologie e.V.
Engeler Daniel, Putora Paul Martin, Plasswilm Ludwig, Seelentag Wolf, Schiefer Johann, Schmid Hans-Peter
Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience
Früh M, Kacsir B, ess s, Cerny T, Rodriguez R, Plasswilm L. Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience. Strahlenther Onkol 2011; 187:561-7.
Jun 27, 2011Extrapulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience
Jun 27, 2011Strahlenther Onkol 2011; 187:561-7
Früh Martin, Kacsir Bela, ess silvia, Cerny Thomas, Rodriguez Regulo, Plasswilm Ludwig